Overcoming Limitations with Immunopeptidomics to Better Identify Molecules on the Tumour Surface & Confirm Actual Tumour Presentation
- Learning advanced Immunopeptidomics workflows to validate true tumour surface antigen presentation
- Addressing sensitivity and detection limits in mass spectrometry to capture low abundance neoantigens
- Integrating immunopeptidomic data with genomic profiling to reduce false positives